Overview
Yasushi Sawayama practices in Nagasaki, Japan. Sawayama is rated as an Experienced expert by MediFind in the treatment of Mononucleosis. Their top areas of expertise are Adult T-Cell Leukemia, Leukemia, Pulmonary Alveolar Proteinosis, Bone Marrow Transplant, and Thymectomy.
Their clinical research consists of co-authoring 68 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Mononucleosis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Adult T-Cell LeukemiaSawayama isDistinguished. Learn about Adult T-Cell Leukemia.
- Advanced
- Bone Marrow TransplantSawayama isAdvanced. Learn about Bone Marrow Transplant.
- LeukemiaSawayama isAdvanced. Learn about Leukemia.
- Pulmonary Alveolar Proteinosis
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Sawayama isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Monoblastic Leukemia (AmoL)Sawayama isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Myeloid Leukemia (AML)Sawayama isExperienced. Learn about Acute Myeloid Leukemia (AML).
- B-Cell LymphomaSawayama isExperienced. Learn about B-Cell Lymphoma.
- CACH SyndromeSawayama isExperienced. Learn about CACH Syndrome.
- Chronic Myelogenous Leukemia (CML)Sawayama isExperienced. Learn about Chronic Myelogenous Leukemia (CML).